跳至主要内容
临床试验/EUCTR2009-014137-25-IT
EUCTR2009-014137-25-IT进行中(未招募)不适用

Monitoring of endothelial dysfunction during chronic administration of vardenafil in patients with type 2 diabetes mellitus: A longitudinal, randomised, placebo-controlled, double blind, phase II b, clinical trial - VARDENAFIL&DIABETES

nita` Operativa di Endocrinologia e Malattie del Metabolismo0 个研究点开始时间: 2009年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • - Male gender; - Signed written Consent Form - Type 2 diabetes mellitus diagnosed within 12 months before enrolment in the study; - Body Mass Index (BMI) < 35; - ED (severe, moderate or light according to the International Index of Erectile Function ? erectile function domain score < 26 (Rosen et al. 1997)); - Age range: 40-60 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Systemic diseases except type 2 diabetes mellitus; - Absence of ED; - Psychiatric disorders; - All contraindications to treatment with PDE5 inhibitors

研究者

发起方
nita` Operativa di Endocrinologia e Malattie del Metabolismo

相似试验